Experiences with Condylox

This page shows detailed information about a drug such as statistics, patient reviews and related articles.

Active ingredient: Podofilox
ATC Code: D06BB04

Level of
Satisfaction

Level of Satisfaction 100%

What patients say...

Effectiveness 87%
Quantity of side effects 37%
Severity of side effects 25%
Ease of use 75%

Our patients

Our patients, demographics

Most common conditions


Read our patient's reviews about Condylox

Filter reviews by...

hide filters...
translation feature available for reviews from other countries
Condylox
3/8/2018 | | 22moderated by Philip
Podofilox (1,5mg/g) for Condyloma

i read that lots of people had troubles with this medication. pain, i can hardly sit, but i have absolutely no problems and the warts are already almost gone. It was a success!
> read full review...

Condylox
9/17/2017 | | 30moderated by Susan
Podofilox (200mg/g) for Condyloma

After noticing four little bumps under my foreskin, I decided to visit the doctor. He confirmed my fears: genital warts. OMG so mortified but started straight away. The first two times the stuff tickled a bit but then it got more painful but still bearable, for me at least. Mild swelling. The last time, on the 3rd day, I noticed that two of the warts had disappeared so I didn't put anything on ...
> read full review...

Most reviewed drugs


The content on this page is user-generated content, read and revised before approval to comply with our standards for a drug review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Copyright © 2008-2024 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.